Rarecyte

Developer of technologies for the analysis of rare and single cells in the blood

placeSeattle, Washington, United States calendar_todayFounded 2009 groups54 employees language rarecyte.com

Registered entities

Social engagement

Social engagement: 6.2K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

13 investors on record; lead investors include Health Quest Capital, 5AM Ventures, Telegraph Hill Partners, F-Prime Capital.

Investor typeCountShare
Venture capital646%
Private equity18%
Bank & private debt18%
Other / undisclosed538%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

3 Mar 2026 · Senior Electrical Engineer · Seattle

Based on job postings tracked across public sources.

Recent activity

30 Jun 2026
Event
Webinar on how Navigate BioPharma Services, Inc.
25 Jun 2026
Event
RareCyte 2026 Calendar Image Contest
9 Jun 2026
Event
EACR2026
Coming soon